BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 36165028)

  • 1. Gastrointestinal symptoms in COVID-19: the long and the short of it.
    Freedberg DE; Chang L
    Curr Opin Gastroenterol; 2022 Nov; 38(6):555-561. PubMed ID: 36165028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nutritional Modulation of Gut Microbiota Alleviates Severe Gastrointestinal Symptoms in a Patient with Post-Acute COVID-19 Syndrome.
    Wang Y; Wu G; Zhao L; Wang W
    mBio; 2022 Apr; 13(2):e0380121. PubMed ID: 35254129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastrointestinal sequalae months after severe acute respiratory syndrome corona virus 2 infection: a prospective, observational study.
    Liptak P; Duricek M; Rosolanka R; Ziacikova I; Kocan I; Uhrik P; Grendar M; Hrnciarova M; Bucova P; Galo D; Banovcin P
    Eur J Gastroenterol Hepatol; 2022 Sep; 34(9):925-932. PubMed ID: 35913778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19: gastrointestinal and hepatobiliary manifestations.
    Shih AR; Misdraji J
    Hum Pathol; 2023 Feb; 132():39-55. PubMed ID: 35843340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paediatric gastrointestinal disorders in SARS-CoV-2 infection: Epidemiological and clinical implications.
    Al-Beltagi M; Saeed NK; Bediwy AS; El-Sawaf Y
    World J Gastroenterol; 2021 Apr; 27(16):1716-1727. PubMed ID: 33967552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal coronavirus disease 2019 manifestations in childhood.
    Sansotta N; Norsa L; D'Antiga L
    Curr Opin Clin Nutr Metab Care; 2022 May; 25(3):195-202. PubMed ID: 35199658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome.
    Liu Q; Mak JWY; Su Q; Yeoh YK; Lui GC; Ng SSS; Zhang F; Li AYL; Lu W; Hui DS; Chan PK; Chan FKL; Ng SC
    Gut; 2022 Mar; 71(3):544-552. PubMed ID: 35082169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-COVID-19 syndrome: epidemiology, diagnostic criteria and pathogenic mechanisms involved.
    Carod-Artal FJ
    Rev Neurol; 2021 Jun; 72(11):384-396. PubMed ID: 34042167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 induces gastrointestinal symptoms and affects patients' prognosis.
    Jin S; Lu X; Xu C
    J Int Med Res; 2022 Oct; 50(10):3000605221129543. PubMed ID: 36238995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long COVID symptoms and duration in SARS-CoV-2 positive children - a nationwide cohort study.
    Borch L; Holm M; Knudsen M; Ellermann-Eriksen S; Hagstroem S
    Eur J Pediatr; 2022 Apr; 181(4):1597-1607. PubMed ID: 35000003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Systematic Review of the Prevalence of Persistent Gastrointestinal Symptoms and Incidence of New Gastrointestinal Illness after Acute SARS-CoV-2 Infection.
    Hawkings MJ; Vaselli NM; Charalampopoulos D; Brierley L; Elliot AJ; Buchan I; Hungerford D
    Viruses; 2023 Jul; 15(8):. PubMed ID: 37631968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut Microbiome Alterations in COVID-19.
    Zuo T; Wu X; Wen W; Lan P
    Genomics Proteomics Bioinformatics; 2021 Oct; 19(5):679-688. PubMed ID: 34560321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diseases of the gastrointestinal tract in the context of COVID-19 infection: present and future challenges: A review].
    Maev IV; Osadchuk MA
    Ter Arkh; 2023 Sep; 95(7):586-590. PubMed ID: 38159010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal Involvement in SARS-CoV-2 Infection.
    Chen TH; Hsu MT; Lee MY; Chou CK
    Viruses; 2022 May; 14(6):. PubMed ID: 35746659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal Correlation Between Neurological and Gastrointestinal Symptoms of SARS-CoV-2.
    Bostancıklıoğlu M
    Inflamm Bowel Dis; 2020 Jul; 26(8):e89-e91. PubMed ID: 32440692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Italian intersociety consensus on management of long covid in children.
    Esposito S; Principi N; Azzari C; Cardinale F; Di Mauro G; Galli L; Gattinara GC; Fainardi V; Guarino A; Lancella L; Licari A; Mancino E; Marseglia GL; Leonardi S; Nenna R; Zampogna S; Zona S; Staiano A; Midulla F
    Ital J Pediatr; 2022 Mar; 48(1):42. PubMed ID: 35264214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut Microbiota Disruption in COVID-19 or Post-COVID Illness Association with severity biomarkers: A Possible Role of Pre / Pro-biotics in manipulating microflora.
    Alharbi KS; Singh Y; Hassan Almalki W; Rawat S; Afzal O; Alfawaz Altamimi AS; Kazmi I; Al-Abbasi FA; Alzarea SI; Singh SK; Bhatt S; Chellappan DK; Dua K; Gupta G
    Chem Biol Interact; 2022 May; 358():109898. PubMed ID: 35331679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can SARS-CoV-2 be transmitted via faeces?
    Moura IB; Buckley AM; Wilcox MH
    Curr Opin Gastroenterol; 2022 Jan; 38(1):26-29. PubMed ID: 34628417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 and Gastrointestinal Tract Symptoms: Recognition, Containment, and Learning From the Past.
    McDermott CV; Cox EJ; Scanlan JM; Alicic RZ
    Mayo Clin Proc; 2020 Nov; 95(11):2320-2324. PubMed ID: 33153620
    [No Abstract]   [Full Text] [Related]  

  • 20. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.